Pharmaceutical News and Articles

One in 7 Americans Has Had Long COVID

As many as 1 in 3 people who fall ill with COVID-19 will develop long COVID, with symptoms that can persist for months or years, a new study estimates.Nearly ha

Critics Slam Updated Infection Control Recommendations for Hospitals

Advisors to the U.S. Centers for Disease Control and Prevention are expected to approve new draft guidelines for hospital infection control this week, the first

More Eye Drops Recalled Due to Infection Danger

Cardinal Health is voluntarily recalling certain LEADER brand eye drops because they may cause eye infections. The U.S. Food and Drug Administration informed th

Hep C Testing Recommendations Developed for Perinatally Exposed Infants

Recommendations have been developed for hepatitis C virus (HCV) testing among perinatally exposed infants. The recommendations and report are published in the N

Last 20 Years Saw Reduction in Prevalence of Elevated LDL Cholesterol

From 1999-2000 to 2017-2020, there was a reduction in the prevalence of elevated low-density lipoprotein cholesterol (LDL-C), although a considerable proportion

Living Alone Tied to Higher Risk for Cancer Death

Adults living alone have a higher risk for cancer death versus those living with others, according to a study published online Oct. 19 in Cancer. Hyunjung Lee,

FDA Approves Wezlana for Multiple Inflammatory Diseases

The U.S. Food and Drug Administration has approved Wezlana (ustekinumab-auub) as a biosimilar to and interchangeable with Stelara (ustekinumab) for multiple inf

Second Person to Receive Pig Heart Dies Six Weeks After Transplant

WEDNESDAY, Nov. 1, 2023 The second person to ever receive a transplanted pig heart has died. Lawrence Faucette, 58, got the transplant just six weeks earlier at

Interventions to Redesign Patient Care Do Not Improve Outcomes

Interventions to redesign care for hospitalized patients are not associated with improved patient outcomes, according to a study published online Oct. 31 in the

FDA Approves Voquezna (vonoprazan) for the Treatment of Erosive GERD and Relief of Heartburn Associated with Erosive GERD in Adults